What is the long-term outcome of the liver allograft?

Journal of Hepatology

Volumn 55, Issue 3, 2011, Pages 702-717

  Hübscher, Stefan G ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

de novo disease; Idiopathic post transplant hepatitis; Late rejection; Liver biopsy; Liver transplantation; Recurrent disease; Tolerence

Indexed keywords

ACUTE GRAFT REJECTION; ALLOGRAFT; ARTICLE; AUTOIMMUNE DISEASE; CHOLANGITIS; CHRONIC GRAFT REJECTION; GRAFT DYSFUNCTION; HEPATITIS; HEPATITIS C; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER HYPERPLASIA; LIVER INJURY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84860390000     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.03.005     Document Type: Note

References (164)

1. S.G. Hubscher, and B.C. Portmann Transplantation pathology A.D. Burt, B.C. Portmann, L.D. Ferrell, MacSween's pathology of the liver 2007 Churchill Livingstone Edinburgh 815 879
2. S.G. Hubscher Recurrent and de-novo disease in the liver allograft Curr Opin Organ Transpl 11 2006 283 288 (Pubitemid 43804782)
3. O. Pappo, H. Ramos, T.E. Starzl, J.J. Fung, and A.J. Demetris Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation Am J Surg Pathol 19 1995 192 206
4. G.I. Slapak, R. Saxena, B. Portmann, E. Gane, J. Devlin, and R. Calne Graft and systemic disease in long-term survivors of liver transplantation Hepatology 25 1997 195 202 (Pubitemid 27015010)
5. M. Berenguer, J.M. Rayon, M. Prieto, V. Aguilera, D. Nicolas, and V. Ortiz Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 7 2001 790 796 (Pubitemid 32851300)
6. M. Sebagh, K. Rifai, C. Feray, F. Yilmaz, B. Falissard, and B. Roche All liver recipients benefit from the protocol 10-year liver biopsies Hepatology 37 2003 1293 1301 (Pubitemid 36667308)
7. S.C. Abraham, J.J. Poterucha, C.B. Rosen, A.J. Demetris, and A.M. Krasinskas Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests Am J Surg Pathol 32 2008 965 973
8. S. Vasani, T. Khan, D. Nikitin, E.Q. Sanchez, S. Chinnakotla, and H.B. Randall Utility of long-term protocol liver biopsy without biochemical graft dysfunction in orthotopic liver transplantation Liver Transpl 14 2008 S207
9. G. Mells, C. Mann, S. Hubscher, and J. Neuberger Late protocol liver biopsies in the liver allograft: a neglected investigation? Liver Transpl 15 2009 931 938
10. W. Gelson, M. Hoare, E. Unitt, C. Palmer, P. Gibbs, and N. Coleman Heterogeneous inflammatory changes in liver graft recipients with normal biochemistry Transplantation 89 2010 739 748
11. V. Fouquet, A. Alves, S. Branchereau, S. Grabar, D. Debray, and E. Jacquemin Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center Liver Transpl 11 2005 152 160 (Pubitemid 40268212)
12. H.M. Evans, D.A. Kelly, P.J. McKiernan, and S. Hubscher Progressive histological damage in liver allografts following pediatric liver transplantation Hepatology 43 2006 1109 1117 (Pubitemid 43724635)
13. P. Bachina, R.M. Taylor, S. Mouat, M. Rela, A.S. Knisely, and B.C. Portmann Liver allograft histology at 10 years and quality of life in children with normal standard liver function tests Hepatology 48 2008 1627
14. U.D. Ekong, H. Melin-Aldana, R. Seshadri, J. Lokar, D. Harris, and P.F. Whitington Graft histology characteristics in long-term survivors of pediatric liver transplantation Liver Transpl 14 2008 1582 1587
15. R. Scheenstra, P.M. Peeters, H.J. Verkade, and A.S. Gouw Graft fibrosis after pediatric liver transplantation: ten years of follow-up Hepatology 49 2009 880 886
16. O.S. Shaikh, and A.J. Demetris Idiopathic posttransplantation hepatitis? Liver Transpl 13 2007 943 946 (Pubitemid 47163182)
17. D.A. Neil, and S.G. Hubscher Current views on rejection pathology in liver transplantation Transpl Int 23 2010 971 983
18. G. Mells, and J. Neuberger Protocol liver allograft biopsies Transplantation 85 2008 1686 1692
19. T. Wong, K.T. Nouri-Aria, J. Devlin, B. Portmann, and R. Williams Tolerance and latent cellular rejection in long-term liver transplant recipients 1 Hepatology 28 1998 443 449 (Pubitemid 28363672)
20. G. Tisone, G. Orlando, A. Cardillo, G. Palmieri, T.M. Manzia, and L. Baiocchi Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence J Hepatol 44 2006 702 709
21. T. Koshiba, Y. Li, M. Takemura, Y. Wu, S. Sakaguchi, and N. Minato Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation Transpl Immunol 17 2007 94 97 (Pubitemid 46240888)
22. M. Yoshitomi, T. Koshiba, H. Haga, Y. Li, X. Zhao, and D. Cheng Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation Transplantation 87 2009 606 614
23. A.J. Demetris, J.G. Lunz III, P. Randhawa, T. Wu, M. Nalesnik, and A.W. Thomson Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective Transpl Int 22 2009 120 141
24. A. Shaked, R.M. Ghobrial, R.M. Merion, T.H. Shearon, J.C. Emond, and J.H. Fair Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation Am J Transplant 9 2009 301 308
25. J. Kemnitz, G. Gubernatis, H. Bunzendahl, B. Ringe, R. Pichlmayr, and A. Georgii Criteria for the histopathological classification of liver allograft rejection and their clinical relevance Transplant Proc 21 1989 2208 2210 (Pubitemid 19131190)
26. Y. Cakaloglu, J. Devlin, J. O'Grady, S. Sutherland, B.C. Portmann, and N. Heaton Importance of concomitant viral infection during late acute liver allograft rejection Transplantation 59 1995 40 45
27. S.G. Hubscher Transplantation pathology Semin Liver Dis 29 2009 74 90
28. S. Hubscher What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl 15 2009 S19 S24
29. A.M. Krasinskas, E.D. Ruchelli, E.B. Rand, J.L. Chittams, and E.E. Furth Central venulitis in pediatric liver allografts Hepatology 33 2001 1141 1147 (Pubitemid 32378213)
30. A.J. Demetris, O. Adeyi, C.O. Bellamy, A. Clouston, F. Charlotte, and A. Czaja Liver biopsy interpretation for causes of late liver allograft dysfunction Hepatology 44 2006 489 501 (Pubitemid 44214890)
31. S.S. Sundaram, H. Melin-Aldana, K. Neighbors, and E.M. Alonso Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients Liver Transpl 12 2006 58 64
32. A.S. Gouw, M.C. van den Heuvel, A.P. van den Berg, M.J. Slooff, K.P. de Jong, and S. Poppema The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection Transplantation 73 2002 243 247 (Pubitemid 34112848)
33. D.A. Neil, and S.G. Hubscher Histologic and biochemical changes during the evolution of chronic rejection of liver allografts Hepatology 35 2002 639 651 (Pubitemid 34183970)
34. Z. Hassoun, V. Shah, C.M. Lohse, V.S. Pankratz, and L.M. Petrovic Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome Liver Transpl 10 2004 480 487 (Pubitemid 38443586)
35. S. Riva, A. Sonzogni, M. Bravi, A. Bertani, M.G. Alessio, and M. Candusso Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience Liver Transpl 12 2006 573 577
36. B. Demirhan, B. Bilezikci, A.N. Haberal, S. Sevmis, Z. Arat, and M. Haberal Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection Liver Transpl 14 2008 214 219 (Pubitemid 351267279)
37. S.G. Hubscher Central perivenulitis: a common and potentially important finding in late posttransplant liver biopsies Liver Transpl 14 2008 596 600 (Pubitemid 351696268)
38. S.C. Abraham, D.K. Freese, M.B. Ishitani, A.M. Krasinskas, and T.T. Wu Significance of central perivenulitis in pediatric liver transplantation Am J Surg Pathol 32 2008 1479 1488
39. A.M. Krasinskas, A.J. Demetris, J.J. Poterucha, and S.C. Abraham The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers Liver Transpl 14 2008 625 632 (Pubitemid 351696273)
40. P. International Banff schema for grading liver allograft rejection: an international consensus document Hepatology 25 1997 658 663
41. G. Junge, S.G. Tullius, V. Klitzing, L. Schewior, J. Pratschke, and C. Radke The influence of late acute rejection episodes on long-term graft outcome after liver transplantation Transplant Proc 37 2005 1716 1717 (Pubitemid 40790807)
42. M.O. Lovell, K.V. Speeg, G.A. Halff, D.K. Molina, and F.E. Sharkey Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode Liver Transpl 10 2004 369 373 (Pubitemid 38380310)
43. L. D'Antiga, A. Dhawan, B. Portmann, R. Francavilla, M. Rela, and N. Heaton Late cellular rejection in paediatric liver transplantation: aetiology and outcome Transplantation 73 2002 80 84 (Pubitemid 34094690)
44. M. Sebagh, K. Blakolmer, B. Falissard, B. Roche, J.F. Emile, and H. Bismuth Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema Hepatology 35 2002 117 125 (Pubitemid 34032551)
45. T. Miloh, M.S. Magid, K. Iyer, N. Kerkar, and R.A. Morotti Chronic rejection preceded by central perivenulitis, rapidly ensuing after liver transplantation in a pediatric patient Semin Liver Dis 29 2009 134 138
46. A.C. Anand, S.G. Hubscher, B.K. Gunson, P. McMaster, and J.M. Neuberger Timing, significance, and prognosis of late acute liver allograft rejection Transplantation 60 1995 1098 1103
47. S. Florman, T. Schiano, L. Kim, D. Maman, A. Levay, and G. Gondolesi The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation Clin Transplant 18 2004 152 155 (Pubitemid 38404645)
48. T. Uemura, T. Ikegami, E.Q. Sanchez, L.W. Jennings, G. Narasimhan, and G.J. McKenna Late acute rejection after liver transplantation impacts patient survival Clin Transplant 22 2008 316 323 (Pubitemid 351689662)
49. Y. Nakazawa, J.R. Jonsson, N.I. Walker, P. Kerlin, C. Steadman, and S.V. Lynch Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection Hepatology 32 2000 1240 1247
50. J.G. Lunz III, S. Contrucci, K. Ruppert, N. Murase, J.J. Fung, and T.E. Starzl Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs Am J Pathol 158 2001 1379 1390 (Pubitemid 32281302)
51. T.C. Schreuder, S.G. Hubscher, and J. Neuberger Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int 22 2009 144 152
52. J.G. O'Grady Phenotypic expression of recurrent disease after liver transplantation Am J Transplant 10 2010 1149 1154
53. G.W. McCaughan, N.A. Shackel, P. Bertolino, and D.G. Bowen Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes Transplantation 87 2009 1105 1111
54. B. Roche, and D. Samuel Hepatitis C virus: up to the minute Liver Transpl 16 2010 S26 S35
55. R.J. Firpi, M.F. Abdelmalek, C. Soldevila-Pico, R. Cabrera, J.J. Shuster, and D. Theriaque One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection Liver Transpl 10 2004 1240 1247 (Pubitemid 39406077)
56. U.P. Neumann, T. Berg, M. Bahra, D. Seehofer, J.M. Langrehr, and R. Neuhaus Fibrosis progression after liver transplantation in patients with recurrent hepatitis C J Hepatol 41 2004 830 836 (Pubitemid 39434314)
57. J.F. Gallegos-Orozco, A. Yosephy, B. Noble, B.A. Aqel, T.J. Byrne, and E.J. Carey Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course Liver Transpl 15 2009 1872 1881
58. T. Zimmermann, C. Otto, M. Hoppe-Lotichius, S. Biesterfeld, A. Lautem, and M. Knaak Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation Transplant Proc 41 2009 2549 2556
59. D. Samuel, and B. Roche Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success J Hepatol 46 2007 988 991 (Pubitemid 46671607)
60. M. Bahra, U.P. Neumann, D. Jacob, J.M. Langrehr, T. Berg, and R. Neuhaus Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy) Transplantation 83 2007 351 353
61. E. Cholongitas, E. Tsochatzis, J. Goulis, and A.K. Burroughs Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review Transpl Int 23 2010 861 870
62. S. Beckebaum, S. Iacob, C.G. Klein, A. Dechene, J. Varghese, and H.A. Baba Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients Transplantation 89 2010 983 993
63. J.A. Carrion, G. Fernandez-Varo, M. Bruguera, J.C. Garcia-Pagan, J.C. Garcia-Valdecasas, and S. Perez-Del-Pulgar Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation Gastroenterology 138 2010 147 158 e141
64. J.A. Carrion, F. Torres, G. Crespo, R. Miquel, J.C. Garcia-Valdecasas, and M. Navasa Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation Hepatology 51 2010 23 34
65. B. Roche, and D. Samuel Risk factors for hepatitis C recurrence after liver transplantation J Viral Hepat 14 2007 89 96 (Pubitemid 47624117)
66. A.J. Demetris Evolution of hepatitis C virus in liver allografts Liver Transpl 15 2009 S35 S41
67. T.K. Narang, W. Ahrens, and M.W. Russo Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria Liver Transpl 16 2010 1228 1235
68. E. Cholongitas, D. Samonakis, D. Patch, M. Senzolo, A.K. Burroughs, and A. Quaglia Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus Transplantation 81 2006 488 490 (Pubitemid 43255742)
69. N. Kontorinis, K. Agarwal, N. Elhajj, M.I. Fiel, and T.D. Schiano Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation Liver Transpl 12 2006 827 830
70. S. Berardi, F. Lodato, A. Gramenzi, A. D'Errico, M. Lenzi, and A. Bontadini High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence. possible de novo autoimmune hepatitis? Gut 56 2007 237 242
71. M. Merli, F. Gentili, M. Giusto, A.F. Attili, S.G. Corradini, and G. Mennini Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis? Dig Liver Dis 41 2009 345 349
72. U. Khettry, W.Y. Huang, M.A. Simpson, E.A. Pomfret, J.J. Pomposelli, and W.D. Lewis Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients Hum Pathol 38 2007 443 452 (Pubitemid 46227528)
73. M.I. Fiel, K. Agarwal, C. Stanca, N. Elhajj, N. Kontorinis, and S.N. Thung Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus Liver Transpl 14 2008 861 871 (Pubitemid 351895516)
74. S.C. Ward, T.D. Schiano, S.N. Thung, and M.I. Fiel Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant Liver Transpl 15 2009 1826 1833
75. M. Berenguer What determines the natural history of recurrent hepatitis C after liver transplantation? J Hepatol 42 2005 448 456 (Pubitemid 40342920)
76. E.J. Gane The natural history of recurrent hepatitis C and what influences this Liver Transpl 14 2008 S36 S44
77. R.A. McTaggart, N.A. Terrault, A.J. Vardanian, A. Bostrom, and S. Feng Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation Liver Transpl 10 2004 975 985 (Pubitemid 39232750)
78. S. Saab, D. Kalmaz, N.A. Gajjar, J. Hiatt, F. Durazo, and S. Han Outcomes of acute rejection after interferon therapy in liver transplant recipients Liver Transpl 10 2004 859 867 (Pubitemid 38979255)
79. C.M. Stanca, M.I. Fiel, N. Kontorinis, K. Agarwal, S. Emre, and T.D. Schiano Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin Transplantation 84 2007 180 186 (Pubitemid 47205751)
80. T. Walter, J. Dumortier, O. Guillaud, V. Hervieu, P. Paliard, and J.Y. Scoazec Rejection under alpha interferon therapy in liver transplant recipients Am J Transplant 7 2007 177 184 (Pubitemid 44952871)
81. I. Fernandez, E. Ulloa, F. Colina, M. Abradelo, C. Jimenez, and A. Gimeno Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C Liver Transpl 15 2009 948 955
82. M. Kugelmas, M.J. Osgood, J.F. Trotter, T. Bak, M. Wachs, and L. Forman Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection Liver Transpl 9 2003 1159 1165 (Pubitemid 37407984)
83. J.F. Trotter, J.C. Osborne, M. Heller, and U. Christians Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients Aliment Pharmacol Ther 22 2005 37 44 (Pubitemid 40943873)
84. M.M. Yeh, A.M. Larson, B.Y. Tung, P.E. Swanson, and M.P. Upton Endothelitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis Am J Surg Pathol 30 2006 727 733 (Pubitemid 44264998)
85. P. Souza, T.J. Prihoda, A.M. Hoyumpa, and F.E. Sharkey Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C Hum Pathol 40 2009 92 97
86. A. Regev, E. Molina, R. Moura, P.A. Bejarano, A. Khaled, and P. Ruiz Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation Liver Transpl 10 2004 1233 1239 (Pubitemid 39406076)
87. A.J. Demetris, B. Eghtesad, A. Marcos, K. Ruppert, M.A. Nalesnik, and P. Randhawa Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis Am J Surg Pathol 28 2004 658 669 (Pubitemid 38579570)
88. J.R. Burton Jr., and H.R. Rosen Acute rejection in HCV-infected liver transplant recipients: the great conundrum Liver Transpl 12 2006 S38 S47 (Pubitemid 44742524)
89. A. Grassi, C. Quarneti, M. Ravaioli, F. Bianchini, M. Susca, and A. D'Errico Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C Liver Transpl 12 2006 1673 1681 (Pubitemid 44742548)
90. A. Errico-Grigioni, M. Fiorentino, F. Vasuri, E. Gruppioni, B. Fabbrizio, and N. Zucchini Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation Liver Transpl 14 2008 313 320 (Pubitemid 351425485)
91. H. Sadamori, T. Yagi, H. Iwagaki, H. Matsuda, S. Shinoura, and Y. Umeda Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation J Gastroenterol Hepatol 24 2009 574 580
92. A. Jain, R. Mohanka, M. Orloff, P. Abt, J. Romano, and L. Bryan Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies Clin Transplant 20 2006 624 633 (Pubitemid 44383409)
93. R. Lorho, B. Turlin, N. Aqodad, N. Triki, A.S. Lajarte-Thirouard, and C. Camus C4d: a marker for hepatic transplant rejection Transplant Proc 38 2006 2333 2334 (Pubitemid 46068533)
94. M. Schmeding, A. Dankof, V. Krenn, M.G. Krukemeyer, M. Koch, and A. Spinelli C4d in acute rejection after liver transplantation - a valuable tool in differential diagnosis to hepatitis C recurrence Am J Transplant 6 2006 523 530 (Pubitemid 43382138)
95. G.C. MacQuillan, W.B. de Boer, J.E. Allan, M.A. Platten, W.D. Reed, and G.P. Jeffrey Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation Clin Transplant 24 2010 252 258
96. E. Unitt, W. Gelson, S.E. Davies, N. Coleman, and G.J. Alexander Minichromosome maintenance protein-2-positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation Liver Transpl 15 2009 306 312
97. N. Kerkar, N. Hadzic, E.T. Davies, B. Portmann, P.T. Donaldson, and M. Rela De-novo autoimmune hepatitis after liver transplantation Lancet 351 1998 409 413 (Pubitemid 28064165)
98. M. Salcedo, J. Vaquero, R. Banares, M. Rodriguez-Mahou, E. Alvarez, and J.L. Vicario Response to steroids in de novo autoimmune hepatitis after liver transplantation Hepatology 35 2002 349 356 (Pubitemid 34106374)
99. A. Miyagawa-Hayashino, H. Haga, H. Egawa, Y. Hayashino, T. Sakurai, and S. Minamiguchi Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation Transplantation 78 2004 128 135
100. I. Aguilera, J.M. Sousa, F. Gavilan, A. Bernardos, I. Wichmann, and A. Nunez-Roldan Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation Liver Transpl 10 2004 1166 1172 (Pubitemid 39255364)
101. I. Aguilera, J.M. Sousa, F. Gavilan, A. Bernardos, I. Wichmann, and A. Nunez-Roldan Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation Transplant Proc 37 2005 3968 3969 (Pubitemid 43015226)
102. Y. Avitzur, B.Y. Ngan, M. Lao, A. Fecteau, and V.L. Ng Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation J Pediatr Gastroenterol Nutr 45 2007 222 227 (Pubitemid 47220531)
103. M. Rodriguez-Mahou, M. Salcedo, E. Fernandez-Cruz, J.L. Tiscar, R. Banares, and G. Clemente Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation Transplantation 83 2007 1126 1129 (Pubitemid 46659126)
104. R.S. Venick, S.V. McDiarmid, D.G. Farmer, J. Gornbein, M.G. Martin, and J.H. Vargas Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis Am J Transplant 7 2007 955 963 (Pubitemid 46481195)
105. M. Salcedo, M. Rodriguez-Mahou, C. Rodriguez-Sainz, D. Rincon, E. Alvarez, and J.L. Vicario Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation Liver Transpl 15 2009 530 539
106. I. Aguilera, J.M. Sousa, J.M. Praena, M.A. Gomez-Bravo, and A. Nunez-Roldan Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation Clin Transplant 10 2010
107. A. Richter, E. Grabhorn, K. Helmke, M.P. Manns, R. Ganschow, and M. Burdelski Clinical relevance of autoantibodies after pediatric liver transplantation Clin Transplant 21 2007 427 432 (Pubitemid 46711410)
108. A.W. Lohse, P. Obermayer-Straub, G. Gerken, S. Brunner, U. Altes, and H.P. Dienes Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease - possible association with a steroid-resistant transplant rejection episode J Hepatol 31 1999 149 155 (Pubitemid 29287621)
109. J.C. Duclos-Vallee, C. Johanet, J.F. Bach, and A.M. Yamamoto Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis J Hepatol 33 2000 163 166 (Pubitemid 30418950)
110. A. Inui, T. Sogo, H. Komatsu, H. Miyakawa, and T. Fujisawa Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation Liver Transpl 11 2005 504 507 (Pubitemid 40704061)
111. K. Yoshizawa, H. Shirakawa, T. Ichijo, T. Umemura, E. Tanaka, and K. Kiyosawa De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis Clin Transplant 22 2008 385 390 (Pubitemid 351689672)
112. T. Grammatikopoulos, M.G. Mytilinaiou, D.P. Bogdanos, R.J. Thompson, N. Hadzic, and G. Mieli-Vergani Glutathionine S-transferase theta 1 (Gstt1) mismatch does not account for post liver transplant de novo autoimmune hepatitis Hepatology 50 2009 635A 636A
113. S. Huguet, J. Vinh, C. Johanet, D. Samuel, M. Gigou, and O. Zamfir Identification by proteomic tool of atypical anti-liver/kidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantation Ann NY Acad Sci 1109 2007 345 357 (Pubitemid 47511378)
114. P. Jara, L. Hierro, P. Martinez-Fernandez, R. Varez-Doforno, F. Yanez, and M.C. Diaz Recurrence of bile salt export pump deficiency after liver transplantation N Engl J Med 361 2009 1359 1367
115. V. Keitel, M. Burdelski, Z. Vojnisek, L. Schmitt, D. Haussinger, and R. Kubitz De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis Hepatology 50 2009 510 517
116. G. Maggiore, E. Gonzales, M. Sciveres, M.J. Redon, B. Grosse, and B. Stieger Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2 J Hepatol 53 2010 981 986
117. A.W. Lohse, C. Weiler-Norman, and M. Burdelski De novo autoimmune hepatitis after liver transplantation Hepatol Res 37 2007 S462
118. A.J. Demetris, and M. Sebagh Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis? Liver Transpl 14 2008 750 755 (Pubitemid 351895504)
119. M. Pagadala, S. Dasarathy, B. Eghtesad, and A.J. McCullough Posttransplant metabolic syndrome: an epidemic waiting to happen Liver Transpl 15 2009 1662 1670
120. K.D. Watt Obesity and metabolic complications of liver transplantation Liver Transpl 16 2010 S65 S71
121. J. Dumortier, E. Giostra, S. Belbouab, I. Morard, O. Guillaud, and L. Spahr Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil" Am J Gastroenterol 105 2010 613 620
122. J. Ong, Z.M. Younossi, V. Reddy, L.L. Price, T. Gramlich, and J. Mayes Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease Liver Transpl 7 2001 797 801 (Pubitemid 32851301)
123. G. Ayata, F.D. Gordon, W.D. Lewis, E. Pomfret, J.J. Pomposelli, and R.L. Jenkins Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation Hum Pathol 33 2002 1098 1104 (Pubitemid 35416707)
124. F. Poordad, R. Gish, A. Wakil, R. Garcia-Kennedy, P. Martin, and F.Y. Yao De novo non-alcoholic fatty liver disease following orthotopic liver transplantation Am J Transplant 3 2003 1413 1417 (Pubitemid 37288087)
125. L.G. Lim, C.L. Cheng, A. Wee, S.G. Lim, Y.M. Lee, and D.S. Sutedja Prevalence and clinical associations of posttransplant fatty liver disease Liver Int 27 2007 76 80 (Pubitemid 46139430)
126. S. Seo, K. Maganti, M. Khehra, R. Ramsamooj, A. Tsodikov, and C. Bowlus De novo nonalcoholic fatty liver disease after liver transplantation Liver Transpl 13 2007 844 847 (Pubitemid 46947849)
127. K. Yalamanchili, S. Saadeh, G.B. Klintmalm, L.W. Jennings, and G.L. Davis Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease Liver transpl 16 2010 431 439
128. M. Alsatie, P. Pandya, and N.P. Chalasani Insulin resistance, hepatitis C, and liver transplantation Liver Transpl 14 2008 136 137 (Pubitemid 351267267)
129. S.J. Cotler, E. Kallwitz, V. TenCate, A. Bhushan, J. Berkes, and E. Benedetti Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation Transplantation 84 2007 587 591 (Pubitemid 47429038)
130. A. Delgado-Borrego, Y.S. Liu, S.H. Jordan, S. Agrawal, H. Zhang, and M. Christofi Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance Liver Transpl 14 2008 193 201 (Pubitemid 351267276)
131. M.F. Abdelmalek, and A.M. Diehl De novo nonalcoholic fatty liver disease after liver transplantation Liver Transpl 13 2007 788 790 (Pubitemid 46939432)
132. P. Rosenthal, J.C. Emond, M.B. Heyman, J. Snyder, J. Roberts, and N. Ascher Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients Liver Transpl Surg 3 1997 559 562 (Pubitemid 27498466)
133. P. Burra, D. Mioni, A. Cecchetto, U. Cillo, G. Zanus, and S. Fagiuoli Histological features after liver transplantation in alcoholic cirrhotics J Hepatol 34 2001 716 722 (Pubitemid 32488787)
134. M.A. Heneghan, T. Zolfino, P. Muiesan, B.C. Portmann, M. Rela, and N.D. Heaton An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis Liver Transpl 9 2003 921 928 (Pubitemid 37098840)
135. D. Herzog, D.B. Soglio, J.C. Fournet, S. Martin, D. Marleau, and F. Alvarez Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients Liver Transpl 14 2008 946 955 (Pubitemid 352003893)
136. J. Neuberger Chronic allograft dysfunction: diagnosis and management. Is it always progressive? Liver Transpl 11 2005 S63 S68 (Pubitemid 43072618)
137. W.K. Syn, P. Nightingale, B. Gunson, S.G. Hubscher, and J.M. Neuberger Natural history of unexplained chronic hepatitis after liver transplantation Liver Transpl 13 2007 984 989 (Pubitemid 47163190)
138. M. Seyam, J.M. Neuberger, B.K. Gunson, and S.G. Hubscher Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence Liver Transpl 13 2007 966 974 (Pubitemid 47163188)
139. S. Nagai, M. Ito, H. Kamei, T. Nakamura, H. Ando, and T. Kiuchi Indirect immunohistochemical evaluation of graft fibrosis and interface hepatitis after pediatric liver transplantation Pediatr Transplant 14 2010 342 350
140. A. Miyagawa-Hayashino, H. Haga, H. Egawa, Y. Hayashino, S. Uemoto, and T. Manabe Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome Transpl Int 22 2009 303 312
141. E.B. Haagsma, A.P. van den Berg, R.J. Porte, C.A. Benne, H. Vennema, and J.H. Reimerink Chronic hepatitis E virus infection in liver transplant recipients Liver Transpl 14 2008 547 553 (Pubitemid 351524412)
142. N. Kamar, J. Selves, J.M. Mansuy, L. Ouezzani, J.M. Peron, and J. Guitard Hepatitis E virus and chronic hepatitis in organ-transplant recipients N Engl J Med 358 2008 811 817 (Pubitemid 351281642)
143. S. Pischke, P.V. Suneetha, C. Baechlein, H. Barg-Hock, A. Heim, and N. Kamar Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients Liver Transpl 16 2010 74 82
144. N. Kamar, F. Abravanel, J. Selves, C. Garrouste, L. Esposito, and L. Lavayssiere Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation Transplantation 89 2010 353 360
145. F. Legrand-Abravanel, N. Kamar, K. Sandres-Saune, C. Garrouste, M. Dubois, and J.M. Mansuy Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France J Infect Dis 202 2010 835 844
146. E.B. Haagsma, A. Riezebos-Brilman, A.P. van den Berg, R.J. Porte, and H.G. Niesters Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b Liver Transpl 16 2010 474 477
147. M. Buti, C. Cabrera, R. Jardi, L. Castells, and R. Esteban Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl 16 2010 106 107
148. R. Mohamed, S.G. Hubscher, D.F. Mirza, B.K. Gunson, and D.J. Mutimer Posttransplantation chronic hepatitis in fulminant hepatic failure Hepatology 25 1997 1003 1007 (Pubitemid 27157148)
149. J.C. Duclos-Vallee, M. Sebagh, K. Rifai, C. Johanet, E. Ballot, and C. Guettier A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence Gut 52 2003 893 897 (Pubitemid 36613499)
150. M. Sebagh, O. Farges, L. Dubel, D. Samuel, H. Bismuth, and M. Reynes Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation Transplantation 65 1998 1328 1333 (Pubitemid 28283094)
151. U. Khettry, A. Keaveny, A. Goldar-Najafi, W.D. Lewis, E.A. Pomfret, and J.J. Pomposelli Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study Hum Pathol 34 2003 1127 1136 (Pubitemid 37466998)
152. S.R. Martin, P. Russo, J. Dubois, and F. Alvarez Centrilobular fibrosis in long-term follow-up of pediatric liver transplant recipients Transplantation 74 2002 828 836
153. P.M. Peeters, E. Sieders, H.M. vd, C.M. Bijleveld, K.P. de Jong, and E.M. TenVergert Predictive factors for portal fibrosis in pediatric liver transplant recipients Transplantation 70 2000 1581 1587 (Pubitemid 32037970)
154. E. Sieders, B.G. Hepkema, P.M. Peeters, E.M. TenVergert, K.P. de Jong, and R.J. Porte The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation Liver Transpl 11 2005 1541 1549 (Pubitemid 43072631)
155. H. Devarbhavi, S. Abraham, and P.S. Kamath Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation Liver Transpl 13 2007 1552 1556 (Pubitemid 350168196)
156. A. Krasinskas The significance of nodular regenerative hyperplasia in the transplanted liver Liver Transpl 13 2007 1496 1497 (Pubitemid 350168186)
157. E. Gane, B. Portmann, R. Saxena, P. Wong, J. Ramage, and R. Williams Nodular regenerative hyperplasia of the liver graft after liver transplantation Hepatology 20 1994 88 94 (Pubitemid 24196495)
158. R. Huang, T.D. Schiano, M.J. Amolat, C.M. Miller, S.N. Thung, and R. Saxena Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients Liver Transpl 10 2004 1461 1467 (Pubitemid 40028377)
159. A. Sanchez-Fueyo Identification of operationally tolerant liver transplant recipients Liver Transpl 16 2010 S82 S86
160. S. Feng Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant 13 2008 506 512
161. A. Talisetti, M. Hurwitz, M. Sarwal, W. Berquist, R. Castillo, and D. Bass Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients Pediatr Transplant 14 2010 976 979
162. Y. Li, X. Zhao, D. Cheng, H. Haga, T. Tsuruyama, and K. Wood The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients Transplantation 86 2008 1837 1843
163. G.V. Mazariegos, J. Reyes, I.R. Marino, A.J. Demetris, B. Flynn, and W. Irish Weaning of immunosuppression in liver transplant recipients Transplantation 63 1997 243 249 (Pubitemid 27121206)
164. J.C. Magee Graft fibrosis in stable pediatric liver transplant recipients: what does it mean? Hepatology 49 2009 726 728